Nachrichten zur Merck & Co Aktie

Insider trades: Merck, Intel, Micron among notable names

…

Mercks Subdued 2026 Outlook: What it Means After Q4 Results?

MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected…

Merck veteran Perlmutter-led Eikon ?Therapeutics valued at $860 million in Nasdaq debut

Drug developer Eikon Therapeutics , headed by Merck veteran Roger Perlmutter, was valued at about $860.3 million after its shares…

Amgen (AMGN) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, Feb. 3, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChairman, President & Chief Executive Officer — Robert…

ROUNDUP: US-Pharmakonzern Merck & Co enttäuscht mit Prognose für 2026

RAHWAY (dpa-AFX) - Der US-Pharmariese Merck & Co nimmt sich für 2026 weiteres Wachstum vor.…

Merck & Co Aktie: Konservativer Jahresausblick

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI),…

Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Merck posted a modest 2026 outlook that fell short of estimates, as it prepares for some drugs to go off…

US-Pharmakonzern Merck & Co enttäuscht mit Prognose für 2026

RAHWAY (dpa-AFX) - Der US-Pharmariese Merck & Co nimmt sich für 2026 weiteres Wachstum vor.…

Merck and Pfizer decline vs the broader market as results released

The pharma industry is handling big transitions, as highlighted in Mercks and Pfizers earnings, released Tuesday…

+++ Geschäftszahlen +++: Sartorius erreicht Ziele für 2025 – Wachstum erwartet

Paypal verfehlt Erwartungen +++ US-Pharmakonzern Merck korrigiert Ausblick nach unten +++ Nintendo verfehlt Gewinnerwartungen trotz Switch-2-Absatz +++ Der Newsblog.…

DZ Bank belässt Merck KGaA auf Kaufen - Fairer Wert 150 Euro

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Merck KGaA auf "Kaufen" mit einem fairen Wert von…

Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more

These are the stocks posting the largest moves in early trading.…

Merck forecasts 2026 sales below estimates on patent losses

Merck & Co on Tuesday forecast 2026 sales and profits below Wall Street estimates as the loss of patent exclusivity…

Merck shares dip as 2026 outlook misses Wall Street expectations

Merck & Co Inc (NYSE:MRK, XETRA:6MK) shares fell 2% at Tuesday’s opening bell after the drugmaker issued a 2026 outlook…

BARCLAYS stuft MERCK KGAA auf Equal Weight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Merck KGaA mit einem Kursziel von 130 Euro…

MRK Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 26 View

Merck tops Q4 EPS and sales estimates as Keytruda drives growth, but shares fall in pre-market trading as 2026 guidance…

Investor Joe Terranova likes Merck despite pharmaceutical firms move to lower drug price

Merck will report its earnings on Tuesday, offering insights into how its agreement to lower the price of its diabetes…

Merck (MRK) Advances While Market Declines: Some Information for Investors

Merck (MRK) reached $110.42 at the closing of the latest trading day, reflecting a +1.92% change compared to its last…

Why the Market Dipped But Merck (MRK) Gained Today

Merck (MRK) closed at $108.34 in the latest trading session, marking a +1.35% move from the prior day.…

Führungswechsel: Merck beruft Benjamin Hein zum neuen Chef der Elektroniksparte

Der vorherige Service-Geschäft-Leiter löst zum 1. Mai Kai Beckmann ab. Der Personalwechsel räumt auch auch dessen angekündigten Weg an die…

Curious about Merck (MRK) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Looking beyond Wall Streets top-and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a…

Mercks Non-Oncology Drugs Q4 Performance: What to Expect

MRKs focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health…

Merck & Co Aktie: Citigroup sieht mit Kursziel 115 USD mehr Wert, aber kein klares Kaufsignal

Bad Marienberg (www.aktiencheck.de) - Merck & Co: Wenn ein höheres Kursziel keine Kaufempfehlung istMerck & Co Inc. (ISIN: US58933Y1055, WKN:…

Merck führt keine Gespräche mehr über den Kauf von Revolution Medicines

Die Unternehmen hatten über einen Deal im Wert von rund 30 Mrd. USD verhandelt.   Der Angriff auf das medikamentös nicht angreifbar…

Merck ends acquisition talks with Revolution Medicines

Merck ends acquisition talks with Revolution Medicines - WSJ…

Merck (MRK) Rises Higher Than Market: Key Facts

Merck (MRK) concluded the recent trading session at $111.11, signifying a +1.52% move from its prior days close.…

Will Weak Gardasil Sales Continue to Ail MRK Revenues in Q4 Earnings?

Gardasils sharp sales slump in China and Japan puts Merck under pressure heading into Q4 earnings, with the vaccines sales…

EQS-News: Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation (deutsch)

Merck und ChemLex unterzeichnen Absichtserklärung zur Förderung der automatisierten Chemie und technologischen Innovation^EQS-News: ChemLex / Schlagwort(e): VertragMerck und ChemLex unterzeichnen…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 150 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach der JPMorgan Healthcare Conference auf…

Why Mercks 32% Rally Isnt Enough to Change the Bearish View

MRK is up over 32% in three months, but declining estimates, Keytrudas upcoming LOE and Gardasil declines keep the stock…

Merck (MRK) Gains As Market Dips: What You Should Know

Merck (MRK) closed at $111.01 in the latest trading session, marking a +2.54% move from the prior day.…

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s By Reuters

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s…

Merck says new growth opportunities to drive revenue of $70 billion by mid-2030s

Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these…

Merck Aktie: Goldman-Sachs-Analyst setzt auf Nachholpotenzial - Kommt jetzt die Kursjagd?

Bad Marienberg (www.aktiencheck.de) - Merck: im Aufholmodus: Goldman Sachs hebt Kursziel auf 155 Euro an - Rating "buy" bleibt, Fantasie…

Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

Key deals this week: Merck, Glencore, CrowdStrike, Marvell Technology, Steel Dynamics and more

…

Merck in Talks to Buy Revolution Medicines Per Financial Times Report

Merck is in talks to acquire RVMD, which could bolster its oncology pipeline, according to a Financial Times report.…

Merck (MRK) Surpasses Market Returns: Some Facts Worth Knowing

Merck (MRK) concluded the recent trading session at $110.99, signifying a +2.2% move from its prior days close.…

Merck in talks to buy biotech Revolution Medicines, FT reports

Merck is in talks to buy cancer drug developer Revolution Medicines , the Financial Times reported on Thursday, citing people…

Merck & Co Aktie: Pharma-Sektor am Wendepunkt

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse der UBS:UBS habe das Kursziel für die Aktie von Merck & Co Inc. (ISIN:…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The highest-yielding stocks in the Dow are Verizon, Chevron, and Merck, but should you buy any of them?…

Merck & Co Aktie 2026: Phase-3-Daten und CADENCE-Studie im Fokus der Analysten

San Francisco (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Wells Fargo:Die Analysten von Wells Fargo haben die Aktie von Merck &…

Merck (MRK) Laps the Stock Market: Heres Why

The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.13% change from its previous close.…

Merck: A Pharma Giant Trading At A Decade-Low Valuation While Executing Its Post-Keytruda Playbook

…

Merck: Framework For Success

…

Merck: A Post-2028 Slowdown Doesnt Kill The Long-Term Thesis

…

Why Merck (MRK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Why Merck (MRK) Outpaced the Stock Market Today

The latest trading day saw Merck (MRK) settling at $106.45, representing a +1.34% change from its previous close.…

Pharmakonzern: Merck erhält Zulassung für Tumormittel in China

Das Tumormittel Pimicotinib soll das erste Medikament sein, das in China die Zulassung zur Behandlung spezieller Tumore erhalten hat. Auch…

Aktien von Merck, Roche, Novartis & Co.: US-Regierung erzielt Preisdeal mit neun Pharmafirmen

Am Freitagabend teilte die US-Regierung mit, dass sie mit neun internationalen Pharmafirmen, darunter die Roche-Tochter Genentech und Novartis, eine…